10 Jul
2016
Smart syringes are engineered to prevent and protect the person being injected, from serious needle stick injuries, blood-borne diseases, such as hepatitis B virus (HBV) and human immunodeficiency virus (HIV), and other deadly infections. Featuring retractable needles in robust designs, where all components are interlocked after automatic retraction, these smart syringes self-destruct after a single use.
A recent 2014 study sponsored by WHO, which focused on the most recent available data, estimated that in the year 2010, up to 1.7 million people were infected with hepatitis B virus, 315 000 with hepatitis C virus and 33, 800 with HIV caused by unsafe injection practices. Earlier in 2015, the World Health Organization announced a new policy on medical practice, injection safety, mandating a full transition to safety-engineered smart syringes by the end of 2020. The new WHO injection safety guidelines and policy released in January 2015 contained detailed recommendations, highlighting the value of safety features for syringes, also including devices that would protect health workers against accidental needle injury and expose them to infection.
Meanwhile, the launch of global campaigns to raise awareness among population in various countries shall help tackle the issue of unsafe medical practices mainly due to reused injections. These countries are mostly under-developed and developing nations in which a large part of rural population rely on quacks, unlicensed medical personnel and doctors for their daily health needs and the pressure for using reused syringes is quite huge. For instance, the initiation of an HIV outbreak around 2015, in the village of Roka in Cambodia, was traced back to syringe reuse. As many as 272 people were tested positive for HIV through the end of 2014 to early 2016.
Read more about smart syringes market at: https://www.alliedmarketresearch.com/smart-syringes-market
People around the globe seem quite persuaded on efficacy of medicine delivered via syringe, as compared to alternative oral medications. However, they lack awareness regarding safe practices that inhibits the reuse of syringes. Cost constraints may lead them towards a large grey market of used syringes, which needs to be discouraged by healthcare providers and clinicians.
Companies have taken the matter of educating their consumer base seriously after the WHO guidelines were released. Smart Pad 2.0 by Noble presents an example of how learning guides can be incorporated in the packaging of syringes itself. This is possible through embedded sensors and on-chip technologies. These assist the user detect any unintentional misuse and provides active learning. On-board interactive panels ease the case even further.
Manufacturers consequentially fall into the responsibility of engineering designs that discourage reuse of injections. Cost-cutting had, at one time, driven them to switch from glass bodies to plastic ones. It was stipulated that practitioners would not be able to distil the equipment without distorting its shape. Although it did not stop them from reuse, but increased risks several notches further.
Advanced design implementations, however, have resolved injection-associated issues. WHO guidelines mark a prominent turning point in the smart syringes industry. Foremost of all effects, there would be fresh demand for billions of units from healthcare practitioners, and self-administering individuals. Prices will be jacked up given the low involvement of companies in smart syringe segment. Inspired by the profit making prospect, manufacturers will be lured into the production of the same. As the number of manufacturers grow in the segment, a cost-competitive scenario shall dawn upon the industry, balancing out the prices for consumers.
During the present decade, market for smart syringes is growing at a significant rate. As per a recent report by Allied Market Research titled “World Smart Syringes Market - Opportunities and Forecasts, 2014 – 2020.” The devices cater to a wide spectrum of applications such as vaccination, drug delivery, and blood specimen collection. The global market was evaluated at $4.8 billion in 2015, and would reach $7.6 billion by 2020, growing at a CAGR of 9.6% over the forecast period. Active safety syringes accounts for the highest revenue in 2015 and they are the most common type used across healthcare sectors, whereas, auto disable (AD) syringes segment are prominently used for vaccination purposes.
Akhilesh Prabhugaonkar
Author's Bio- Akhilesh Prabhugaonkar holds a bachelors degree in Electronics Engineering from the reputed Vishwakarma Institute of Technology. He has a special interest in the fields of forensics, world history, international relations and foreign policy, sports, agriculture, astronomy, security, and oceanography. An ardent bibliophile and melophile, Akhilesh loves to write on topics of his interest and various other societal issues. This love for writing made him enter the professional world of content writing and pursue his career in this direction.
Which Ambient Light Sensor Industry Trends Can Optimize Your Business Potential?
Which Types of Life Reinsurance Policies Should Your Business Invest In?
How Have Multi-access Edge Computing and 5G Technology Revolutionized the IIoT and Other Sectors?
Citric Acid: Reasons Behind the Rising Demand from Food & Beverage and Manufacturing Businesses
Which Hybrid Electric Car Industry Trends Should Your Business Take Note of?
Mulcher Attachment Equipment: Is It a Game-Changing Tool for Promoting Agricultural Activities?
How Advanced Outdoor Decor Trends Boost Your Business Revenue?
Unveiling the Versatile Role of Sodium Sulfate in Reshaping Various Industries